Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CL-197 in Treatment-Naive HIV-1 Patients
NCT07308782Phase 2Recruiting
- Sponsor
- Genuine Biotech
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of CL-197 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Genuine Biotech. Started Nov 2025; status: recruiting.
02
Drugs
CL-197
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT07308782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07308782.